Cover Image
Market Research Report

EUROPE CARDIOVASCULAR ULTRASOUND SYSTEM MARKET 2018 -2026

Published by Inkwood Research Product code 618285
Published Content info 95 Pages
Delivery time: 1-2 business days
Price
Back to Top
EUROPE CARDIOVASCULAR ULTRASOUND SYSTEM MARKET 2018 -2026
Published: March 26, 2018 Content info: 95 Pages
Description

KEY FINDINGS

The Europe cardiovascular ultrasound system market is predicted to dominate the global scene by the end of the forecast period of 2018-2026. Over these estimated years, the market is anticipated to rise with a 5.94% CAGR.

MARKET INSIGHTS

Growing research and development and rising miniature models of ultrasound machines due to rapidly growing demand for mobile-based ultrasound devices are presenting the market with amazing growth opportunities. The German market is anticipated to showcase the highest CAGR by the end of 2026. In Germany, more than 310 of every 100000 people die from cardiovascular diseases every year. To deal with this issue, the German government is enthusiastically involved in various researches in echocardiography, which in turn, is promoting the market for cardiovascular ultrasound systems in the region.

COMPETITIVE INSIGHTS

Industry experts like Mindray Medical International Limited, Abbott Vascular Inc, Esaote S.P.A, Unetixs Vascular Inc, Boston Scientific Corporation, Ge Healthcare Inc, Ultrasound Technologies Ltd, Atricure Inc, Fujifilm Holdings Corporation, Philips Healthcare, Stryker Corporation and Toshiba Medical Systems Corporation are engaged in this market.

Table of Contents
Product Code: 16319

Table of Contents

1. RESEARCH SCOPE

  • 1.1. STUDY GOALS
  • 1.2. SCOPE OF THE MARKET STUDY
  • 1.3. WHO WILL FIND THIS REPORT USEFUL?
  • 1.4. STUDY AND FORECASTING YEARS

2. RESEARCH METHODOLOGY

  • 2.1. SOURCES OF DATA
    • 2.1.1. SECONDARY DATA
    • 2.1.2. PRIMARY DATA
  • 2.2. TOP DOWN APPROACH
  • 2.3. BOTTOM-UP APPROACH
  • 2.4. DATA TRIANGULATION

3. EXECUTIVE SUMMARY

  • 3.1. MARKET SUMMARY
  • 3.2. KEY FINDINGS
    • 3.2.1. CONTINUOUS INNOVATION IN CARDIAC ULTRASOUND SYSTEMS
    • 3.2.2. 2D CARDIOVASCULAR ULTRASOUND SYSTEM IS THE LEADING TECHNOLOGY
    • 3.2.3. HOSPITALS AND CARDIOLOGY CENTERS ARE THE MARKET LEADERS IN TERMS OF END USERS

4. MARKET DETERMINANTS

  • 4.1. MARKET DRIVERS
    • 4.1.1. ESCALATING PREVALENCE OF CARDIOVASCULAR DISEASES
    • 4.1.2. GROWING HEALTHCARE EXPENDITURE
    • 4.1.3. ADVANCES IN TECHNOLOGY
    • 4.1.4. GROWING DEMAND FOR MINIMALLY INVASIVE PROCEDURES
  • 4.2. MARKET RESTRAINTS
    • 4.2.1. HIGH COST OF SURGERIES
    • 4.2.2. GROWING IMPLEMENTATION OF NOVEL AND ALTERNATE TECHNOLOGIES
    • 4.2.3. UNFAVOURABLE REIMBURSEMENT POLICY
  • 4.3. MARKET OPPORTUNITIES
    • 4.3.1. INCREASE IN THE RESEARCH AND DEVELOPMENT
    • 4.3.2. RISING MINIATURE MODELS OF ULTRASOUND MACHINES DUE TO RAPIDLY GROWING DEMAND OF MOBILE BASED ULTRASOUND DEVICES
  • 4.4. MARKET CHALLENGES
    • 4.4.1. HIGH COST OF INTERVENTIONAL CARDIOLOGY PROCEDURES
    • 4.4.2. COMPLICATIONS ASSOCIATED WITH USAGE OF INTERVENTIONAL CARDIOLOGY DEVICES

5. MARKET SEGMENTATION

  • 5.1. MARKET BY TEST TYPE 2018-2026
    • 5.1.1. TRANSTHORACIC ECHOCARDIOGRAM
    • 5.1.2. TRANSESOPHAGEAL ECHOCARDIOGRAM
    • 5.1.3. STRESS ECHOCARDIOGRAM
    • 5.1.4. OTHER ECHOCARDIOGRAM
  • 5.2. MARKET BY TECHNOLOGY 2018-2026
    • 5.2.1. 2D ULTRASOUND
    • 5.2.2. 3D & 4D ULTRASOUND
    • 5.2.3. DOPPLER IMAGING
  • 5.3. MARKET BY DISPLAY DEVICE 2018-2026
    • 5.3.1. COLOUR DISPLAY
    • 5.3.2. BLACK & WHITE DISPLAY
  • 5.4. MARKET BY END USER 2018-2026
    • 5.4.1. HOSPITAL & CARDIOLOGY CENTERS
    • 5.4.2. HOME & AMBULATORY CARE SETTINGS
    • 5.4.3. OTHER END USERS

6. KEY ANALYTICS

  • 6.1. PORTER'S FIVE FORCE MODEL
    • 6.1.1. BARGAINING POWER OF BUYER
    • 6.1.2. BARGAINING POWER OF SUPPLIER
    • 6.1.3. INTENSITY OF COMPETITIVE RIVALRY
    • 6.1.4. THREATS OF NEW ENTRANTS
    • 6.1.5. THREAT OF SUBSTITUTE PRODUCTS
  • 6.2. VALUE CHAIN ANALYSIS
    • 6.2.1. SUPPLIERS
    • 6.2.2. MANUFACTURERS
    • 6.2.3. DISTRIBUTORS & RETAILERS
    • 6.2.4. END USERS
  • 6.3. MARKET ANALYSIS
    • 6.3.1. PARENT MARKET ANALYSIS
    • 6.3.2. SUBSTITUTE MARKET
  • 6.4. KEY BUYING CRITERIA
    • 6.4.1. QUALITY
    • 6.4.2. PRICE
    • 6.4.3. PORTABILITY
    • 6.4.4. AVAILABILITY
    • 6.4.5. TECHNOLOGY & INNOVATIONS
    • 6.4.6. SUCCESS RATE
  • 6.5. REGULATORY FRAMEWORK

7. GEOGRAPHICAL ANALYSIS

  • 7.1. EUROPE
    • 7.1.1. THE UK
    • 7.1.2. FRANCE
    • 7.1.3. GERMANY
    • 7.1.4. RUSSIA
    • 7.1.5. ITALY
    • 7.1.6. BENELUX
    • 7.1.7. REST OF EUROPE

8. COMPANY PROFILES

  • 8.1. COMPETITIVE ANALYSIS
    • 8.1.1. MARKET SHARE ANALYSIS
    • 8.1.2. TOP COMPANIES
    • 8.1.3. KEY COMPANY STRATEGIES
      • 8.1.3.1. MERGER & ACQUISITION
      • 8.1.3.2. COLLABORATION& PARTNERSHIP
      • 8.1.3.3. LAUNCH OF PRODUCTS
  • 8.2. ABBOTT VASCULAR INC.
    • 8.2.1. COMPANY OVERVIEW
    • 8.2.2. PRODUCT PORTFOLIO
    • 8.2.3. STRATEGIC INITIATIVES
    • 8.2.4. SCOT ANALYSIS
  • 8.3. ATRICURE INC
    • 8.3.1. COMPANY OVERVIEW
    • 8.3.2. PRODUCT PORTFOLIO
    • 8.3.3. STRATEGIC INITIATIVES
    • 8.3.4. SWOT ANALYSIS
  • 8.4. BOSTON SCIENTIFIC CORPORATION
    • 8.4.1. COMPANY OVERVIEW
    • 8.4.2. PRODUCT PORTFOLIO
    • 8.4.3. STRATEGIC INITIATIVES
    • 8.4.4. SWOT ANALYSIS
  • 8.5. CHISON MEDICAL IMAGING CO. LTD.
    • 8.5.1. COMPANY OVERVIEW
    • 8.5.2. PRODUCT PORTFOLIO
    • 8.5.3. STRATEGIC INITIATIVE
    • 8.5.4. SCOT ANALYSIS
  • 8.6. ESAOTE S.P.A
    • 8.6.1. COMPANY OVERVIEW
    • 8.6.2. PRODUCT PORTFOLIO
    • 8.6.3. STRATEGIC ANALYSIS
    • 8.6.4. SCOT ANALYSIS
  • 8.7. FUJIFILM HOLDINGS CORPORATION
    • 8.7.1. COMPANY OVERVIEW
    • 8.7.2. PRODUCT PORTFOLIO
    • 8.7.3. STRATEGIC INITIATIVES
    • 8.7.4. SCOT ANALYSIS
  • 8.8. GE HEALTHCARE INC.
    • 8.8.1. COMPANY OVERVIEW
    • 8.8.2. PRODUCT PORTFOLIO
    • 8.8.3. STRATEGY INITIATIVES
    • 8.8.4. SCOT ANALYSIS
  • 8.9. HITACHI MEDICAL CORPORATION
    • 8.9.1. COMPANY OVERVIEW
    • 8.9.2. PRODUCTS PORTFOLIO
    • 8.9.3. SCOT ANALYSIS
  • 8.10. MINDRAY MEDICAL INTERNATIONAL LIMITED
    • 8.10.1. COMPANY OVERVIEW
    • 8.10.2. PRODUCT PORTFOLIO
    • 8.10.3. STRATEGIC INITIATIVES
    • 8.10.4. SCOT ANALYSIS
  • 8.11. PHILIPS HEALTHCARE
    • 8.11.1. COMPANY OVERVIEW
    • 8.11.2. PRODUCT PORTFOLIO
    • 8.11.3. STRATEGIC INITIATIVES
    • 8.11.4. SCOT ANALYSIS
  • 8.12. SAMSUNG ELECTRONICS CO. LTD.
    • 8.12.1. COMPANY OVERVIEW
    • 8.12.2. PRODUCT PORTFOLIO
    • 8.12.3. STRATEGIC INITIATIVE
    • 8.12.4. SCOT ANALYSIS
  • 8.13. STRYKER CORPORATION
    • 8.13.1. COMPANY OVERVIEW
    • 8.13.2. PRODUCTS PORTFOLIO
    • 8.13.3. SCOT ANALYSIS
  • 8.14. TOSHIBA MEDICAL SYSTEMS CORPORATION (ACQUIRED BY CANON INC.)
    • 8.14.1. COMPANY OVERVIEW
    • 8.14.2. PRODUCT PORTFOLIO
    • 8.14.3. STRATEGIC INITIATIVES
    • 8.14.4. SWOT ANALYSIS
  • 8.15. ULTRASOUND TECHNOLOGIES LTD.
    • 8.15.1. COMPANY OVERVIEW
    • 8.15.2. PRODUCT PORTFOLIO
    • 8.15.3. SCOT ANALYSIS
  • 8.16. UNETIXS VASCULAR INC. (ACQUIRED BY OPTO CIRCUITS)
    • 8.16.1. COMPANY OVERVIEW
    • 8.16.2. PRODUCT PORTFOLIO
    • 8.16.3. STRATEGIC INITIATIVES
    • 8.16.4. SCOT ANALYSIS

TABLE LIST

  • TABLE 1 EUROPE CARDIOVASCULAR ULTRASOUND SYSTEM MARKET 2018 -2026 ($ MILLION)
  • TABLE 2 EUROPE CARDIOVASCULAR ULTRASOUND MARKET BY TEST TYPES 2018-2026 ($ MILLION)
  • TABLE 3 EUROPE CARDIOVASCULAR ULTRASOUND MARKET IN TRANSTHORACIC ECHOCARDIOGRAM 2018-2026 ($ MILLION)
  • TABLE 4 EUROPE CARDIOVASCULAR ULTRASOUND MARKET IN TRANSESOPHAGEAL ECHOCARDIOGRAM 2018-2026 ($ MILLION)
  • TABLE 5 EUROPE CARDIOVASCULAR ULTRASOUND MARKET IN STRESS ECHOCARDIOGRAM 2018-2026 ($ MILLION)
  • TABLE 6 EUROPE CARDIOVASCULAR ULTRASOUND MARKET IN OTHER ECHOCARDIOGRAM 2018-2026 ($ MILLION)
  • TABLE 7 EUROPE CARDIOVASCULAR ULTRASOUND MARKET BY TECHNOLOGY 2018-2026 ($ MILLION)
  • TABLE 8 EUROPE CARDIOVASCULAR ULTRASOUND MARKET IN 2D ULTRASOUND 2018-2026 ($ MILLION)
  • TABLE 9 EUROPE CARDIOVASCULAR ULTRASOUND MARKET IN 3D & 4D ULTRASOUND 2018-2026 ($ MILLION)
  • TABLE 10 EUROPE CARDIOVASCULAR ULTRASOUND MARKET IN DOPPLER IMAGING 2018-2026 ($ MILLION)
  • TABLE 11 EUROPE CARDIOVASCULAR ULTRASOUND MARKET BY DISPLAY DEVICE 2018-2026 ($ MILLION)
  • TABLE 12 EUROPE CARDIOVASCULAR ULTRASOUND MARKET IN COLOUR DISPLAY 2018-2026 ($ MILLION)
  • TABLE 13 EUROPE CARDIOVASCULAR ULTRASOUND MARKET IN BLACK & WHITE DISPLAY 2018-2026 ($ MILLION)
  • TABLE 14 EUROPE CARDIOVASCULAR ULTRASOUND MARKET BY END USERS 2018-2026 ($ MILLION)
  • TABLE 15 EUROPE CARDIOVASCULAR ULTRASOUND MARKET IN HOSPITAL & CARDIOLOGY CENTERS 2018-2026 ($ MILLION)
  • TABLE 16 EUROPE CARDIOVASCULAR ULTRASOUND MARKET IN HOME & AMBULATORY CARE SETTINGS 2018-2026 ($ MILLION)
  • TABLE 17 EUROPE CARDIOVASCULAR ULTRASOUND MARKET IN OTHER END USERS 2018-2026 ($ MILLION)
  • TABLE 18 EUROPE CARDIOVASCULAR ULTRASOUND MARKET 2018-2026 ($ MILLION)
  • TABLE 19 THE UK CARDIOVASCULAR ULTRASOUND MARKET BY TEST TYPE 2018-2026 ($ MILLION)
  • TABLE 20 THE UK CARDIOVASCULAR ULTRASOUND MARKET BY TECHNOLOGY 2018-2026 ($ MILLION)
  • TABLE 21 THE UK CARDIOVASCULAR ULTRASOUND MARKET BY DISPLAY DEVICE 2018-2026 ($ MILLION)
  • TABLE 22 THE UK CARDIOVASCULAR ULTRASOUND MARKET BY END USER 2018-2026 ($ MILLION)
  • TABLE 23 FRANCE CARDIOVASCULAR ULTRASOUND MARKET BY TEST TYPE 2018-2026 ($ MILLION)
  • TABLE 24 FRANCE CARDIOVASCULAR ULTRASOUND MARKET BY TECHNOLOGY 2018-2026 ($ MILLION)
  • TABLE 25 FRANCE CARDIOVASCULAR ULTRASOUND MARKET BY DISPLAY DEVICE 2018-2026 ($ MILLION)
  • TABLE 26 FRANCE CARDIOVASCULAR ULTRASOUND MARKET BY END USER 2018-2026 ($ MILLION)
  • TABLE 27 GERMANY CARDIOVASCULAR ULTRASOUND MARKET BY TEST TYPE 2018-2026 ($ MILLION)
  • TABLE 28 GERMANY CARDIOVASCULAR ULTRASOUND MARKET BY TECHNOLOGY 2018-2026 ($ MILLION)
  • TABLE 29 GERMANY CARDIOVASCULAR ULTRASOUND MARKET BY DISPLAY DEVICE 2018-2026 ($ MILLION)
  • TABLE 30 GERMANY CARDIOVASCULAR ULTRASOUND MARKET BY END USER 2018-2026 ($ MILLION)
  • TABLE 31 RUSSIA CARDIOVASCULAR ULTRASOUND MARKET BY TEST TYPE 2018-2026 ($ MILLION)
  • TABLE 32 RUSSIA CARDIOVASCULAR ULTRASOUND MARKET BY TECHNOLOGY 2018-2026 ($ MILLION)
  • TABLE 33 RUSSIA CARDIOVASCULAR ULTRASOUND MARKET BY DISPLAY DEVICE 2018-2026 ($ MILLION)
  • TABLE 34 RUSSIA CARDIOVASCULAR ULTRASOUND MARKET BY END USER 2018-2026 ($ MILLION)
  • TABLE 35 ITALY CARDIOVASCULAR ULTRASOUND MARKET BY TEST TYPE 2018-2026 ($ MILLION)
  • TABLE 36 ITALY CARDIOVASCULAR ULTRASOUND MARKET BY TECHNOLOGY 2018-2026 ($ MILLION)
  • TABLE 37 ITALY CARDIOVASCULAR ULTRASOUND MARKET BY DISPLAY DEVICE 2018-2026 ($ MILLION)
  • TABLE 38 ITALY CARDIOVASCULAR ULTRASOUND MARKET BY END USER 2018-2026 ($ MILLION)
  • TABLE 39 BENELUX CARDIOVASCULAR ULTRASOUND MARKET BY TEST TYPE 2018-2026 ($ MILLION)
  • TABLE 40 BENELUX CARDIOVASCULAR ULTRASOUND MARKET BY TECHNOLOGY 2018-2026 ($ MILLION)
  • TABLE 41 BENELUX CARDIOVASCULAR ULTRASOUND MARKET BY DISPLAY DEVICE 2018-2026 ($ MILLION)
  • TABLE 42 BENELUX CARDIOVASCULAR ULTRASOUND MARKET BY END USER 2018-2026 ($ MILLION)
  • TABLE 43 REST OF EUROPE CARDIOVASCULAR ULTRASOUND MARKET BY TEST TYPE 2018-2026 ($ MILLION)
  • TABLE 44 REST OF EUROPE CARDIOVASCULAR ULTRASOUND MARKET BY TECHNOLOGY 2018-2026 ($ MILLION)
  • TABLE 45 REST OF EUROPE CARDIOVASCULAR ULTRASOUND MARKET BY DISPLAY DEVICE 2018-2026 ($ MILLION)
  • TABLE 46 REST OF EUROPE CARDIOVASCULAR ULTRASOUND MARKET BY END USER 2018-2026 ($ MILLION)
  • FIGURES LIST
  • FIGURE 1 EUROPE CARDIOVASCULAR ULTRASOUND SYSTEM MARKET 2018 -2026 ($ MILLION)
  • FIGURE 2 EUROPE CARDIOVASCULAR ULTRASOUND MARKET IN TRANSTHORACIC ECHOCARDIOGRAM 2018-2026 ($ MILLION)
  • FIGURE 3 EUROPE CARDIOVASCULAR ULTRASOUND MARKET IN TRANSESOPHAGEAL ECHOCARDIOGRAM 2018-2026 ($ MILLION)
  • FIGURE 4 EUROPE CARDIOVASCULAR ULTRASOUND MARKET IN STRESS ECHOCARDIOGRAM 2018-2026 ($ MILLION)
  • FIGURE 5 EUROPE CARDIOVASCULAR ULTRASOUND MARKET IN OTHER ECHOCARDIOGRAM 2018-2026 ($ MILLION)
  • FIGURE 6 EUROPE CARDIOVASCULAR ULTRASOUND MARKET IN 2D ULTRASOUND 2018-2026 ($ MILLION)
  • FIGURE 7 EUROPE CARDIOVASCULAR ULTRASOUND MARKET IN 3D & 4D ULTRASOUND 2018-2026 ($ MILLION)
  • FIGURE 8 EUROPE CARDIOVASCULAR ULTRASOUND MARKET IN DOPPLER IMAGING 2018-2026 ($ MILLION)
  • FIGURE 9 EUROPE CARDIOVASCULAR ULTRASOUND MARKET IN COLOUR DISPLAY 2018-2026 ($ MILLION)
  • FIGURE 10 EUROPE CARDIOVASCULAR ULTRASOUND MARKET IN BLACK & WHITE DISPLAY 2018-2026 ($ MILLION)
  • FIGURE 11 EUROPE CARDIOVASCULAR ULTRASOUND MARKET IN HOSPITAL & CARDIOLOGY CENTERS 2018-2026 ($ MILLION)
  • FIGURE 12 EUROPE CARDIOVASCULAR ULTRASOUND MARKET IN HOME & AMBULATORY CARE SETTINGS 2018-2026 ($ MILLION)
  • FIGURE 13 EUROPE CARDIOVASCULAR ULTRASOUND MARKET IN OTHER END USERS 2018-2026 ($ MILLION)
  • FIGURE 14 INVESTMENT PROPOSITION FOR EUROPE CARDIOVASCULAR ULTRASOUND SYSTEM MARKET IN 2017
  • FIGURE 15 REGULATORY FRAMEWORKS IN CARDIOVASCULAR ULTRASOUND MARKET
  • FIGURE 16 EUROPE CARDIOVASCULAR ULTRASOUND MARKET 2018-2026 ($ MILLION)
  • FIGURE 17 THE UK CARDIOVASCULAR ULTRASOUND MARKET 2018-2026 ($ MILLION)
  • FIGURE 18 FRANCE CARDIOVASCULAR ULTRASOUND MARKET 2018-2026 ($ MILLION)
  • FIGURE 19 GERMANY CARDIOVASCULAR ULTRASOUND MARKET 2018-2026 ($ MILLION)
  • FIGURE 20 RUSSIA CARDIOVASCULAR ULTRASOUND MARKET 2018-2026 ($ MILLION)
  • FIGURE 21 ITALY CARDIOVASCULAR ULTRASOUND MARKET 2018-2026 ($ MILLION)
  • FIGURE 22 BENELUX CARDIOVASCULAR ULTRASOUND MARKET 2018-2026 ($ MILLION)
  • FIGURE 23 REST OF EUROPE CARDIOVASCULAR ULTRASOUND MARKET 2018-2026 ($ MILLION)
  • FIGURE 24 CARDIOVASCULAR ULTRASOUND SYSTEM MARKET SHARE 2017(%)
Back to Top